As of March 2021, the proportion of Canadian adults who would not get a coronavirus vaccine if it became available to them was around 12 percent. This statistic shows the percentage of respondents in Canada who would and would not get vaccinated against the coronavirus if a vaccine became avail...
The Centers for Disease Control and Prevention (CDC)recommendeda second dose of the 2024-2025 COVID-19 vaccine, administered 6 months after the first dose, for people aged 65 years or older and individuals who are immunocompromised. Additional doses of the vaccine can maximize protecti...
The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has granted Valneva's covid-19 vaccine (VLA2001) conditional marketing authorisation for use in people aged 18 to 50 years, with the first and second doses to be taken at least 28 days apart....
Biotech Innovations October 12, 2021 India’s New COVID-19 DNA Vaccine for Adolescents and Adults Is a First Jennifer Abbasi JAMA. 2021;326(14):1365. doi:10.1001/jama.2021.16625 COVID-19 Resource Center related articles icon Related Articles Medical News & Perspectives COVID-19 and mRNA ...
The United States has reached something of a turning point in its COVID-19 vaccination campaign, with ten states opening vaccine eligibility to all adults in coming days. This is what the Centers for Disease Control terms Phase 2 of vaccine elig...
adults aged 50 and older, 45% said they were very or somewhat likely to get the new vaccine. About 47% said they were very or somewhat unlikely to do so, and 8% were unsure. Even if you’re otherwise healthy, your immune system naturally slows and weakens as you age. But the more...
JERUSALEM, Dec. 30 (Xinhua) -- The Israeli Ministry of Health on Thursday night said it has approved the administration of the fourth booster vaccine shot against COVID-19 for the adults at high risk. Nachman Ash, director general of the ministry, approved the fourth vaccine shot for those...
Health Minister Budi Gunadi Sadikin told a press conference that those who had received Sinovac vaccine for their first and second doses would be given Pfizer or AstraZeneca boosters. Those who received AstraZeneca vaccine would be given Moderna. ...
SEOUL, Feb. 10 (Korea Bizwire)—South Korea’s drug safety agency on Wednesday approved the vaccine for the novel coronavirus by AstraZeneca for all adults, including those aged 65 and older, amid efficacy controversies. The vaccine developed by the British-Swedish pharmaceutical giant and Oxford...
The COVID-19 vaccine has been a miraculous, life-saving advance, offering staggering efficacy in adults, and was developed with astonishing speed. The time from sequencing the virus to authorizing the first COVID-19 vaccine was so brisk even the optimists appear close-minded. Yet, simultaneously...